Treatment of estrogen receptor-negative or hormonally refractory breast cancer with double high-dose chemotherapy intensification and bone marrow support.

Source:http://linkedlifedata.com/resource/pubmed/id/2358837

Download in:

View as

General Info

PMID
2358837